Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neuropeptide Y expression marks partially differentiated β cells in mice and humans
Pope Rodnoi, Mohan Rajkumar, Abu Saleh Md Moin, Senta K. Georgia, Alexandra E. Butler, Sangeeta Dhawan
Pope Rodnoi, Mohan Rajkumar, Abu Saleh Md Moin, Senta K. Georgia, Alexandra E. Butler, Sangeeta Dhawan
View: Text | PDF
Research Article Development Endocrinology

Neuropeptide Y expression marks partially differentiated β cells in mice and humans

  • Text
  • PDF
Abstract

β Cells are formed in embryonic life by differentiation of endocrine progenitors and expand by replication during neonatal life, followed by transition into functional maturity. In this study, we addressed the potential contribution of neuropeptide Y (NPY) in pancreatic β cell development and maturation. We show that NPY expression is restricted from the progenitor populations during pancreatic development and marks functionally immature β cells in fetal and neonatal mice and humans. NPY expression is epigenetically downregulated in β cells upon maturation. Neonatal β cells that express NPY are more replicative, and knockdown of NPY expression in neonatal mouse islets reduces replication and enhances insulin secretion in response to high glucose. These data show that NPY expression likely promotes replication and contributes to impaired glucose responsiveness in neonatal β cells. We show that NPY expression reemerges in β cells in mice fed with high-fat diet as well as in diabetes in mice and humans, establishing a potential new mechanism to explain impaired β cell maturity in diabetes. Together, these studies highlight the contribution of NPY in the regulation of β cell differentiation and have potential applications for β cell supplementation for diabetes therapy.

Authors

Pope Rodnoi, Mohan Rajkumar, Abu Saleh Md Moin, Senta K. Georgia, Alexandra E. Butler, Sangeeta Dhawan

×

Figure 3

NPY+ β cells represent functionally immature cells.

Options: View larger image (or click on image) Download as PowerPoint
NPY+ β cells represent functionally immature cells.
(A) Immunostaining o...
(A) Immunostaining of representative pancreatic sections from embryonic mice (E17.5) and humans (16 weeks gestation sample: USC repository) for NPY (red), β cell transcription factor Nkx6.1 (green), and insulin (Ins; cyan). DAPI (blue) marks the nuclei. Scale bar: 50 μm. Insets show high-magnification images of the boxed regions (original magnification, ×2). (B) Immunostaining of a representative pancreatic section from wild-type neonatal mice at P1 showing NPY (green), β cell transcription factor MafA (red), and an overlay with DAPI (to counterstain the nuclei; blue). Scale bar: 40 μm. (C) A representative pancreatic section from a P5 NPY-GFP reporter mouse, showing humanized Renilla reniformis GFP (hrGFP) expression driven by the NPY promoter. hrGFP expression is shown in green, with DAPI in blue. Scale bar: 40 μm. (D) Transcript levels for indicated genes in the NPY-expressing, GFP+ (P5 NPY-GFP+) and NPY-non-expressing, GFP– (P5 NPY-GFP–) cell fractions sorted from neonatal (P5) NPY-GFP islets, in comparison with β cells sorted from P21 MIP-GFP+ mice. In the MIP-GFP mice GFP expression is driven by mouse insulin promoter (MIP) to label β cells. P values shown mark the statistical significance of each sample compared with neonatal NPY-expressing β cells (P5 NPY-GFP+). n = 4 animals. The error bars represent SEM of the mean. *P < 0.05, 1-way ANOVA followed by Bonferroni’s post-hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts